Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis.
Hanafin PO, Sermet-Gaudelus I, Griese M, Kappler M, Ellemunter H, Schwarz C, Wilson J, Tan M, Velkov T, Rao GG, Schneider-Futschik EK.
Hanafin PO, et al. Among authors: kappler m.
Front Pharmacol. 2021 Aug 2;12:577263. doi: 10.3389/fphar.2021.577263. eCollection 2021.
Front Pharmacol. 2021.
PMID: 34408649
Free PMC article.